202 related articles for article (PubMed ID: 16845440)
1. Ziconotide: a new option for refractory pain.
Prommer E
Drugs Today (Barc); 2006 Jun; 42(6):369-78. PubMed ID: 16845440
[TBL] [Abstract][Full Text] [Related]
2. Ziconotide: can we use it in palliative care?
Prommer EE
Am J Hosp Palliat Care; 2005; 22(5):369-74. PubMed ID: 16225359
[TBL] [Abstract][Full Text] [Related]
3. Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.
Klotz U
Int J Clin Pharmacol Ther; 2006 Oct; 44(10):478-83. PubMed ID: 17063978
[TBL] [Abstract][Full Text] [Related]
4. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain.
Miljanich GP
Curr Med Chem; 2004 Dec; 11(23):3029-40. PubMed ID: 15578997
[TBL] [Abstract][Full Text] [Related]
5. Ziconotide for treatment of severe chronic pain.
Schmidtko A; Lötsch J; Freynhagen R; Geisslinger G
Lancet; 2010 May; 375(9725):1569-77. PubMed ID: 20413151
[TBL] [Abstract][Full Text] [Related]
6. [New medications; ziconotide].
Cohen AF; van Bronswijk H
Ned Tijdschr Geneeskd; 2006 Nov; 150(44):2427-8. PubMed ID: 17131701
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of intrathecal ziconotide for the treatment of chronic pain.
Jain KK
Expert Opin Investig Drugs; 2000 Oct; 9(10):2403-10. PubMed ID: 11060815
[TBL] [Abstract][Full Text] [Related]
8. Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
Wermeling DP
Pharmacotherapy; 2005 Aug; 25(8):1084-94. PubMed ID: 16207099
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal ziconotide for refractory chronic pain.
Lynch SS; Cheng CM; Yee JL
Ann Pharmacother; 2006; 40(7-8):1293-300. PubMed ID: 16849624
[TBL] [Abstract][Full Text] [Related]
10. Elan: ziconotide review focused on off-label uses.
Narayana AK
Am J Hosp Palliat Care; 2005; 22(6):408. PubMed ID: 16323709
[No Abstract] [Full Text] [Related]
11. Ziconotide: an update and review.
Williams JA; Day M; Heavner JE
Expert Opin Pharmacother; 2008 Jun; 9(9):1575-83. PubMed ID: 18518786
[TBL] [Abstract][Full Text] [Related]
12. Ziconotide: a clinical update and pharmacologic review.
Pope JE; Deer TR
Expert Opin Pharmacother; 2013 May; 14(7):957-66. PubMed ID: 23537340
[TBL] [Abstract][Full Text] [Related]
13. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.
Wang YX; Gao D; Pettus M; Phillips C; Bowersox SS
Pain; 2000 Feb; 84(2-3):271-81. PubMed ID: 10666532
[TBL] [Abstract][Full Text] [Related]
14. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
Staats PS; Yearwood T; Charapata SG; Presley RW; Wallace MS; Byas-Smith M; Fisher R; Bryce DA; Mangieri EA; Luther RR; Mayo M; McGuire D; Ellis D
JAMA; 2004 Jan; 291(1):63-70. PubMed ID: 14709577
[TBL] [Abstract][Full Text] [Related]
16. Effects of intrathecal administration of ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain.
Wang YX; Pettus M; Gao D; Phillips C; Scott Bowersox S
Pain; 2000 Feb; 84(2-3):151-8. PubMed ID: 10666519
[TBL] [Abstract][Full Text] [Related]
17. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
[TBL] [Abstract][Full Text] [Related]
18. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
Wallace MS
Expert Rev Neurother; 2006 Oct; 6(10):1423-8. PubMed ID: 17078783
[TBL] [Abstract][Full Text] [Related]
19. CNSB004 (Leconotide) causes antihyperalgesia without side effects when given intravenously: a comparison with ziconotide in a rat model of diabetic neuropathic pain.
Kolosov A; Goodchild CS; Cooke I
Pain Med; 2010 Feb; 11(2):262-73. PubMed ID: 20002322
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal ziconotide for neuropathic pain: a review.
Rauck RL; Wallace MS; Burton AW; Kapural L; North JM
Pain Pract; 2009; 9(5):327-37. PubMed ID: 19682321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
